• Categories:P7仿制药
• Author:
• Origin:
• Time of issue:2021-11-20
• Views:0

(Summary description)<table class="res_table">
<thead>
<tr>
<th>Function</th>
<th>Drug</th>
<th>Dosage form</th>
<th>Treatment</th>
</tr>
</thead>
<tbody>
<tr>
<td data-title="Function">Antidiabetics</td>
<td data-title="Drug">
<span>Gliclazide,</span>
<span>Dapagliflozin,</span>
<span>Trelagliptin,</span>
<span>Alogliptin,</span>
<span>Compound hypoglycemic drugs</span>
</td>
<td data-title="Dosage form">Tablets</td>
<td data-title="Treatment">Diabetes</td>
</tr>
<tr>
<td data-title="Function">Diabetic complications</td>
<td data-title="Drug">
<span>Epalrestat,</span>
<span>Lipoic acid,</span>
<span>Mecobalamine,</span>
<span>Pentotheobromine,</span>
<span>Dapagliflozin</span>
</td>
<td data-title="Dosage form">
<span>Small volume injection,</span>
<span>Compressed tablets,</span>
<span>Sustained release tablet </span>
</td>
<td data-title="Treatment">
<span>Diabetes Neuropathies,<span>
<span>Diabetic Nephropathy<span>
</td>
</tr>
<tr>
<td data-title="Function">Field of kidney disease</td>
<td data-title="Drug">
<span>Hemofiltration base replacement solution,</span>
<span>Peritoneal dialysis solution,</span>
<span>Bicarbonate dialysate</span>
</td>
<td data-title="Dosage form">Dialysate</td>
<td data-title="Treatment">Kidney disease universal dialysis</td>
</tr>
<tr>
<td data-title="Function">Field of kidney disease</td>
<td data-title="Drug">Cinacalcet</td>
<td data-title="Dosage form">Tablets</td>
<td data-title="Treatment">Secondary hyperparathyroidism in chronic kidney disease (CKD) patients undergoing maintenance dialysis</td>
</tr>
</tbody>
</table>